Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.
Clinical trial NCT05946460 · UNKNOWN
Trial details
- NCT number
- NCT05946460
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2025-07-10
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.